The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...

Objective and Design: This multicentre, double-blind, randomised, controlled trial evaluated the efficacy of continuous low-dose transdermal estradiol (E 2-TDS) compared with oral conjugated equine ...